康泰生物 (300601)
Shenzhen Kangtai Biological Products Co.,Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 111692.92
- Circulating A-Shares(W): 90039.62
- Earnings Per Share(RMB): 0.0400
- Net Assets Per Share(RMB): 8.1469
- Operating Revenue(W RMB): 206344.30
- Total Profit(W RMB): 20.23
- Net Profit Attributable to Parent(W RMB): 4915.77
- Net Profit Growth Rate(%): -86.00
- Weighted Return on Equity(%): 0.5100
- Operating Cash Flow Per Share(RMB): 0.3250
- Undistributed Profit Per Share(RMB): 1.9017
- Capital Reserve Per Share(RMB): 4.9347
2. Main Business
The main business covers:
- Research, development, production and sales of human vaccines
3. Company Basic Information
- Company Name: Shenzhen Kangtai Biological Products Co., Ltd.
- Listing Date: 2017-02-07
- Industry: Pharmaceutical Manufacturing
- Address: Kangtai Group Building, No. 222 Kefa Road, Science Park Community, Yuehai Street, Nanshan District, Shenzhen City, Guangdong Province
- Website: www.biokangtai.com
- Company Profile: The company was established on December 11, 2002, through the overall restructuring of Kangtai Co., Ltd. into a joint-stock company. On October 24, 2002, Kangtai Co., Ltd. passed a shareholders' resolution to convert the company into a joint-stock company based on the audited net assets of 175 million yuan as of September 30, 2002. On December 11, 2002, the company obtained the "Business License" issued by the Shenzhen Administration for Industry and Commerce.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hangzhou Hekun Enterprise Management Co., Ltd. | General Legal Person | 1600.00 | 1.78 |
| 2 | E Fund ChiNext Board ETF | Fund | 1320.16 | 1.47 |
| 3 | CSI 500 ETF | Fund | 974.13 | 1.08 |
| 4 | China Merchants Guozheng Bio-medicine Index Securities Investment Fund (LOF) Class A | Fund | 882.99 | 0.98 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 798.66 | 0.89 |
| 6 | Yinhua CSI Innovative Pharmaceutical Industry ETF | Fund | 641.63 | 0.71 |
| 7 | Harvest CSI Vaccine and Biotechnology ETF | Fund | 56.40 | 0.06 |
| 8 | China Merchants CSI Vaccine and Biotechnology ETF | Fund | 4.98 | 0.01 |
5. Concept Sectors
- Convertible Bonds
- Biological Vaccine
- Hepatitis Concept
- Innovative Drugs
- Synthetic Biology
- Margin Trading & Securities Lending
- Low-Profit Stock
- Planned Share Reduction
- ChiNext Index
- Small Cap Growth
- Technology 100
- SZSE Growth Index
- ChiNext 300
- ChiNext Blue Chip
- ChiNext Technology
- ChiNext Pharmaceutical
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information